Human OMA1/2010001O09Rik/DAB1 ORF/cDNA clone-Adenovirus particle (NM_145243)

Cat. No.: vGMAP-SPh-245

Pre-made Human OMA1/2010001O09Rik/DAB1 Adenovirus for OMA1 overexpression in-vitro and in-vivo. The OMA1 adenoviral vector excels as a vehicle for transient gene transfection in both stable cell lines and primary cells, including DC cells, macrophages, cardiomyocytes, hepatocytes, and neurons. The purified OMA1-encoding adenovirus also stands out as a quintessential tool for in vivo studies and vaccine research initiatives.

At GM Vector Core (GMVC), we provide bespoke adenovirus development and manufacture various grades of adenoviruses utilizing cutting-edge techniques. Dive deeper into our offerings.

Target products collection

Go to OMA1/2010001O09Rik products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdf MSDS
pdf Datasheet

Product information

Catalog No. Product Name Adenovirus Grade Adenovirus quantity
vGMAP-SPh-245 Human OMA1 Adenovirus particle Research Grade-In vitro 1E+10PFU (1E+10pfu/ml×1ml)
5E+10PFU (1E+10pfu/ml×5ml)
1E+11PFU (1E+10pfu/ml×10ml)
Research Grade-In vivo 1E+11PFU (1E+11pfu/ml×1ml)
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMAP-SPh-245
Gene Name OMA1
Accession Number NM_145243
Gene ID 115209
Species Human
Product Type Adenovirus particle (overexpression)
Insert Length 1575 bp
Gene Alias 2010001O09Rik,DAB1,MPRP-1,MPRP1,peptidase,YKR087C,ZMPOMA1
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Amplicin
ORF Nucleotide Sequence ATGAGCTTCATCTGTGGATTGCAGTCTGCTGCTAGAAACCATGTTTTCTTCCGATTTAATTCACTGTCTAACTGGAGAAAATGTAACACATTAGCATCCACCTCACGGGGCTGTCATCAAGTACAAGTTAACCATATAGTAAATAAGTATCAGGGACTGGGAGTAAATCAGTGTGACAGGTGGAGTTTTCTGCCTGGAAACTTTCATTTTTATAGTACTTTTAACAACAAAAGAACAGGAGGCCTCTCAAGTACCAAAAGTAAGGAAATTTGGAGGATTACCAGCAAATGTACTGTATGGAATGATGCTTTTTCAAGACAGCTGCTAATAAAAGAAGTTACAGCAGTCCCTAGTCTGTCAGTATTGCATCCTCTAAGCCCTGCTTCCATAAGAGCTATTAGGAATTTCCATACTTCTCCACGGTTTCAAGCTGCTCCGGTTCCTCTCTTGTTGATGATTCTTAAACCAGTACAGAAGTTATTTGCAATCATTGTAGGCAGGGGCATAAGGAAATGGTGGCAGGCACTTCCTCCTAACAAGAAGGAAGTAGTTAAAGAAAATATAAGGAAGAATAAATGGAAGCTATTCCTTGGTTTGAGTAGTTTTGGATTGCTCTTTGTGGTGTTTTATTTTACTCACCTGGAAGTAAGTCCAATCACAGGAAGGAGCAAGCTACTATTATTGGGGAAAGAACAGTTCAGACTTTTATCGGAACTGGAATATGAAGCATGGATGGAAGAATTTAAAAATGATATGCTAACTGAGAAAGATGCCCGATACCTGGCTGTTAAAGAAGTGCTTTGTCATCTAATTGAATGCAATAAAGATGTTCCAGGGATCTCTCAGATCAATTGGGTTATTCATGTGGTTGATTCCCCAATTATTAATGCCTTCGTGCTTCCAAATGGACAAATGTTTGTTTTCACTGGATTTTTAAATAGTGTAACCGATATTCATCAACTTTCTTTCCTTCTGGGCCATGAAATAGCACATGCAGTACTTGGGCATGCTGCAGAAAAGGCTGGCATGGTTCATTTGTTGGATTTCCTAGGTATGATTTTCCTCACAATGATTTGGGCCATTTGTCCTCGAGATAGCTTGGCACTTTTGTGCCAGTGGATACAGTCTAAATTGCAGGAGTATATGTTTAATAGACCATACAGCAGAAAATTGGAGGCCGAAGCTGACAAAATTGGACTACTGCTTGCTGCAAAGGCTTGTGCAGACATAAGAGCCAGTTCAGTGTTTTGGCAGCAAATGGAGTTCGTTGATAGCCTGCATGGCCAACCCAAGATGCCAGAATGGTTATCTACACACCCTTCTCATGGCAATCGAGTTGAGTACTTGGATAGACTTATACCTCAGGCTCTCAAAATTAGAGAGATGTGTAATTGTCCACCACTGTCTAATCCAGACCCTCGATTACTATTCAAACTCAGCACGAAGCATTTTCTTGAAGAATCAGAGAAAGAAGACCTAAATATCACGAAGAAACAGAAAATGGATACTCTTCCTATTCAAAAACAGGAGCAAATACCATTAACATACATAGTTGAGAAAAGAACGGGCAGTTGA
ORF Protein Sequence MSFICGLQSAARNHVFFRFNSLSNWRKCNTLASTSRGCHQVQVNHIVNKYQGLGVNQCDRWSFLPGNFHFYSTFNNKRTGGLSSTKSKEIWRITSKCTVWNDAFSRQLLIKEVTAVPSLSVLHPLSPASIRAIRNFHTSPRFQAAPVPLLLMILKPVQKLFAIIVGRGIRKWWQALPPNKKEVVKENIRKNKWKLFLGLSSFGLLFVVFYFTHLEVSPITGRSKLLLLGKEQFRLLSELEYEAWMEEFKNDMLTEKDARYLAVKEVLCHLIECNKDVPGISQINWVIHVVDSPIINAFVLPNGQMFVFTGFLNSVTDIHQLSFLLGHEIAHAVLGHAAEKAGMVHLLDFLGMIFLTMIWAICPRDSLALLCQWIQSKLQEYMFNRPYSRKLEAEADKIGLLLAAKACADIRASSVFWQQMEFVDSLHGQPKMPEWLSTHPSHGNRVEYLDRLIPQALKIREMCNCPPLSNPDPRLLFKLSTKHFLEESEKEDLNITKKQKMDTLPIQKQEQIPLTYIVEKRTGS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP1302-Ab Anti-OMA1 monoclonal antibody
    Target Antigen GM-Tg-g-IP1302-Ag OMA1 protein
    ORF Viral Vector pGMLP-SPh-105 Human OMA1 Lentivirus plasmid
    ORF Viral Vector pGMAP-SPh-245 Human OMA1 Adenovirus plasmid
    ORF Viral Vector pGMAP-SPh-296 Human OMA1 Adenovirus plasmid
    ORF Viral Vector vGMLP-SPh-105 Human OMA1 Lentivirus particle
    ORF Viral Vector vGMAP-SPh-245 Human OMA1 Adenovirus particle
    ORF Viral Vector vGMAP-SPh-296 Human OMA1 Adenovirus particle


    Target information

    Target ID GM-IP1302
    Target Name OMA1
    Gene Group Identifier
    （Target Gene ID in Homo species)         		115209
    Gene ID 100067642 (Equus caballus), 101100067 (Felis catus), 115209 (Homo sapiens), 298282 (Rattus norvegicus)
    489569 (Canis lupus familiaris), 506223 (Bos taurus), 67013 (Mus musculus), 716294 (Macaca mulatta)
    Gene Symbols & Synonyms OMA1,Oma1,DAB1,MPRP1,MPRP-1,YKR087C,ZMPOMA1,peptidase,2010001O09Rik,RGD1304821
    Target Alternative Names 2010001O09Rik,DAB1,MPRP-1,MPRP1,Metalloendopeptidase OMA1,Metalloprotease-related protein 1 (MPRP-1),OMA1,Oma1,Overlapping with the m-AAA protease 1 homolog,RGD1304821,YKR087C,ZMPOMA1,mitochondrial,peptidase
    Uniprot Accession D3ZS74,Q3SZN3,Q96E52,Q9D8H7
    Additional SwissProt Accessions: Q96E52,D3ZS74,Q3SZN3,Q9D8H7
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000009131, ENSG00000162600, ENSCAFG00845006858, ENSBTAG00000017326, ENSMUSG00000035069, ENSMMUG00000022762
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.